Hypertension Clinical Trial
— ADELPHYOfficial title:
App Documentation of Electronic BP Readings in Hypertension
Verified date | July 2017 |
Source | Duke-NUS Graduate Medical School |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Background: Hypertension is the leading attributable risk factor for cardiovascular disease
and death globally. In diagnosing and monitoring hypertensive patient population, home blood
pressure monitoring (HBPM) has been shown to be superior to the office-based blood pressure
(BP) measurement as a predictor of cardiovascular disease and total mortality. However, the
conventional method of HBPM utilizing handwritten BP logbooks has known shortcomings, mainly
attributable to inaccuracy and underreporting of data, as well as the failure to bring the
logbooks to the regular outpatient appointments. In recent years, the availability of home BP
devices with Bluetooth® technology on the market, the increasingly widespread use of
smartphones, and the development of mobile applications (apps) that complement Bluetooth®
enabled BP monitors have expanded the potential for an accurate log of BP data to be
accessible to clinicians. Our study's primary aim is to compare the level of HBPM recording
fidelity using smartphone app versus using a handwritten logbook among the multi-ethnic
hypertensive patient population seen in a district polyclinic located in Pasir Ris,
Singapore. Patient acceptability of the two recording modalities and the association between
the home blood pressure recording fidelity and the patients' socio-demographic background,
self-care profile, clinical factors, and level of exposure to technology is also assessed as
exploratory aims. Our main hypothesis is that the level of fidelity in HBPM recording,
defined as the proportion of scheduled number of home blood pressure readings that is
successfully recorded, regimen compliant, and made available at the final follow up visit,
would be higher for patients who use a smartphone app versus those who maintain a handwritten
logbook.
Methods/design: Open, randomized controlled trial of 80 patients seen at Pasir Ris Polyclinic
randomized to either intervention or control arm and assessed after a 3-week follow up period
Intervention arm: Participants randomized to intervention arm follow a 3-week HBPM regimen
and wirelessly record the BP readings onto a smartphone app using Bluetooth® technology.
Control arm: Participants randomized to control arm follow a 3-week HBPM regimen (identical
to intervention arm) and manually record the BP readings onto a handwritten logbook.
Participants: A convenience sample of 80 patients visiting the study polyclinic was obtained
during the recruitment period (15 Mar 2017 - 15 June 2017).
Outcomes: A trained outcomes assessor will assess each participant's home BP record brought
to the final follow up visit at 3 weeks post-randomization. The primary outcome will be HBPM
recording fidelity, defined as the proportion of scheduled number of home blood pressure
readings that is successfully recorded, regimen compliant, and made available at the final
follow up visit. The participants' level of discomfort during the study, their willingness to
incorporate into their healthcare management the modality of HBPM to which they were
assigned, and their overall impression on their study participation will be assessed by a
participant acceptability questionnaire.
Status | Active, not recruiting |
Enrollment | 80 |
Est. completion date | July 31, 2017 |
Est. primary completion date | July 31, 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 40 Years to 70 Years |
Eligibility |
Inclusion Criteria: - Singaporean citizen or permanent resident - Able to communicate in English - Diagnosis of essential hypertension and on at least one antihypertensive medical therapy - Between 40-70 years of age - Owns a smartphone compatible with the study - Has been visiting the study polyclinic for at least 1 year Exclusion Criteria: - Known cardiac arrhythmia - Known end stage renal disease - Known cancer patient - Known history of stroke - Known history of myocardial infarct - Physical or mental disability that would prevent one's own measurement of home BP (e.g. visual impairment, dementia) - Maximal arm circumference exceeding BP cuff size - Anticipation of extensive travel overseas during study period - Occupation requires night shift - Participating in other clinical trials |
Country | Name | City | State |
---|---|---|---|
Singapore | SingHealth Polyclinics - Pasir Ris | Singapore |
Lead Sponsor | Collaborator |
---|---|
Duke-NUS Graduate Medical School | SingHealth Polyclinics |
Singapore,
Chatellier G, Day M, Bobrie G, Menard J. Feasibility study of N-of-1 trials with blood pressure self-monitoring in hypertension. Hypertension. 1995 Feb;25(2):294-301. — View Citation
Han HR, Lee H, Commodore-Mensah Y, Kim M. Development and validation of the Hypertension Self-care Profile: a practical tool to measure hypertension self-care. J Cardiovasc Nurs. 2014 May-Jun;29(3):E11-20. doi: 10.1097/JCN.0b013e3182a3fd46. — View Citation
Lawes CM, Vander Hoorn S, Rodgers A; International Society of Hypertension. Global burden of blood-pressure-related disease, 2001. Lancet. 2008 May 3;371(9623):1513-8. doi: 10.1016/S0140-6736(08)60655-8. Review. — View Citation
Mengden T, Hernandez Medina RM, Beltran B, Alvarez E, Kraft K, Vetter H. Reliability of reporting self-measured blood pressure values by hypertensive patients. Am J Hypertens. 1998 Dec;11(12):1413-7. — View Citation
Niiranen TJ, Hänninen MR, Johansson J, Reunanen A, Jula AM. Home-measured blood pressure is a stronger predictor of cardiovascular risk than office blood pressure: the Finn-Home study. Hypertension. 2010 Jun;55(6):1346-51. doi: 10.1161/HYPERTENSIONAHA.109.149336. Epub 2010 Apr 12. — View Citation
Ohkubo T, Asayama K, Kikuya M, Metoki H, Hoshi H, Hashimoto J, Totsune K, Satoh H, Imai Y; Ohasama Study. How many times should blood pressure be measured at home for better prediction of stroke risk? Ten-year follow-up results from the Ohasama study. J Hypertens. 2004 Jun;22(6):1099-104. — View Citation
Stergiou GS, Baibas NM, Gantzarou AP, Skeva II, Kalkana CB, Roussias LG, Mountokalakis TD. Reproducibility of home, ambulatory, and clinic blood pressure: implications for the design of trials for the assessment of antihypertensive drug efficacy. Am J Hypertens. 2002 Feb;15(2 Pt 1):101-4. — View Citation
Tamaki S, Nakamura Y, Teramura M, Sakai H, Takayama T, Okabayashi T, Kawashima T, Horie M. The factors contributing to whether or not hypertensive patients bring their home blood pressure record to the outpatient clinic. Intern Med. 2008;47(18):1561-5. Epub 2008 Sep 16. — View Citation
Tinetti ME, Han L, Lee DS, McAvay GJ, Peduzzi P, Gross CP, Zhou B, Lin H. Antihypertensive medications and serious fall injuries in a nationally representative sample of older adults. JAMA Intern Med. 2014 Apr;174(4):588-95. doi: 10.1001/jamainternmed.2013.14764. — View Citation
Wu H, Wang B, Zhu X, Chu G, Zhang Z. A new automatic blood pressure kit auscultates for accurate reading with a smartphone: A diagnostic accuracy study. Medicine (Baltimore). 2016 Aug;95(32):e4538. doi: 10.1097/MD.0000000000004538. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Participant Acceptability of the home blood pressure recording modality within each study arm | A trained outcomes assessor administers the Participant Acceptability Questionnaire to assess the participants' level of discomfort during the study, their willingness to incorporate into their healthcare management the modality of HBPM to which they were assigned, and their overall impression on their study participation. | Baseline visit to 3 weeks post randomization | |
Primary | Home Blood Pressure Recording Fidelity within each study arm | The proportion of scheduled number of home blood pressure readings that is successfully recorded, regimen compliant, and made available at the final follow up visit. | Baseline visit to 3 weeks post randomization | |
Secondary | The association of participants' age with home blood pressure recording fidelity within each study arm | regression coefficient p-value < 0.05 is considered to be statistically significant | Baseline visit to 3 weeks post randomization | |
Secondary | The association of participants' highest level of education with home blood pressure recording fidelity within each study arm | regression coefficient p-value < 0.05 is considered to be statistically significant | Baseline visit to 3 weeks post randomization | |
Secondary | The association of participants' years of smartphone use with home blood pressure recording fidelity within each study arm | regression coefficient p-value < 0.05 is considered to be statistically significant | Baseline visit to 3 weeks post randomization |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04591808 -
Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia
|
Phase 3 | |
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT05433233 -
Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension
|
N/A | |
Completed |
NCT05491642 -
A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses
|
Phase 1 | |
Completed |
NCT03093532 -
A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT05529147 -
The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
|
||
Recruiting |
NCT05976230 -
Special Drug Use Surveillance of Entresto Tablets (Hypertension)
|
||
Recruiting |
NCT06363097 -
Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
|
||
Completed |
NCT06008015 -
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT05387174 -
Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period
|
N/A | |
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Recruiting |
NCT05121337 -
Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension
|
N/A | |
Withdrawn |
NCT04922424 -
Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
|
Phase 1 | |
Active, not recruiting |
NCT05062161 -
Sleep Duration and Blood Pressure During Sleep
|
N/A | |
Not yet recruiting |
NCT05038774 -
Educational Intervention for Hypertension Management
|
N/A | |
Completed |
NCT05087290 -
LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
|
||
Completed |
NCT05621694 -
Exploring Oxytocin Response to Meditative Movement
|
N/A | |
Completed |
NCT05688917 -
Green Coffee Effect on Metabolic Syndrome
|
N/A | |
Recruiting |
NCT05575453 -
OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure
|
N/A |